SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy

Background As immune checkpoint inhibitor (ICI) therapies (PD(L)1 and CTLA-4 inhibitors) are increasingly used for treating malignancy, immune-related adverse events (irAEs) are being encountered by clinicians more frequently. Obesity is a pro-inflammatory metabolic state that has been associated wi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Endocr Soc
Egile Nagusiak: Leiter, Amanda, Jia, Rachel, Carroll, Emily, Brooks, Danielle, Ben Shimol, Jennifer, Eisenberg, Elliot, Galsky, Matthew, Gallagher, Emily
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrine Society 2019
Gaiak:
Adipose Tissue, Appetite, and Obesity
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552273/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-094
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak